InvestorsHub Logo
Followers 1
Posts 757
Boards Moderated 0
Alias Born 12/07/2003

Re: None

Sunday, 01/11/2004 12:54:07 PM

Sunday, January 11, 2004 12:54:07 PM

Post# of 82595
If DNAP reads this board and it's true that Beckman Coulter has purchased the rights from Orchid Biosciences for the options agreement with Dnap, then I wish Dnap would remove Orchid and the PR from the "partnerships" link on the DNAP website. Probably should list BC.


DNAPrint and Orchid Announce Option Agreement

On October 24, 2000, DNAPrint genomics announced an Option agreement with Orchid Biosciences (NASD:ORCH) of Princeton NJ, a leader in high-throughput genotyping. Under the terms of the agreement, Orchid provided DNAPrint an up-front payment for the option to negotiate exclusively for a license to co-develop and/or co-commercialize certain DNAPrint products in the future. The agreement provides DNAPrint with a potential distribution channel and applies to products the company is currently developing, and will develop in the near future.


News Release - October 24, 2000